4BIO Capital Alnylam Pharmaceuticals argenx Arch Venture Partners BioGeneration Ventures (BGV) BioMarin Brandon Capital Candel Therapeutics Critical Path Institute Daiichi Sankyo DROIA Ventures Eli Lilly EQT Life Sciences European Medicines Agency (EMA) Forbion Fudan University Ghent University Gilde Healthcare Goodwin Procter Johnson & Johnson Innovation (JJDC)
| |